Our Pipeline

Apellis’ efforts are focused on developing complement immunotherapies. We believe that this approach can result in broad inhibition of the principal pathways of the complement system and has the potential to effectively control a broad range of serious diseases. 

Apellis Pipeline

THIS WEBSITE USES COOKIES

We use cookies to manage user experiences. Read our Cookie Statement for more information, including the purposes or vendors that we use.
User experience